期刊文献+

羟乙基淀粉系列原料药质量控制研究 被引量:1

Discussion on the control of hydroxyethyl starch series raw material quality
下载PDF
导出
摘要 文章通过文献和报道对羟乙基淀粉系列原料的分类、临床不良反应关联关键质量指标的控制、研究情况进行简述,并强调羟乙基淀粉系列原料药质量标准统一的重要性。 This paper briefly described the classification of a series of hydroxyethyl starch APIs, clinical adverse reactions associated with key indicators of quality control and research situations according to the literature and reports.Moreover,it emphasized the importance of unified quality standards of a series of hydroxyethyl starch APIs.
作者 齐麟 陈仁萍 连传宝 尹建峰 QI Lin CHEN Renping LIAN Chuanbao YIN Jianfeng(Shandong Qidu Pharmaceutical Co., Ltd., Linzi 255400, China Shandong Provincial Key Laboratory of Neuroprotective Drugs, Zibo 255400, China Zibo Food and Drug Administration, Zibo 255400, China Zibo Linzi Food and Drug Administration, Linzi 255400, China)
出处 《药学研究》 CAS 2016年第12期734-736,共3页 Journal of Pharmaceutical Research
关键词 羟乙基淀粉系列原料 不良反应 质量标准 Hydroxyethyl starch APIs Adverse reactions Quality standards
  • 相关文献

参考文献7

二级参考文献45

  • 1罗逸,刘菊蓉,郭兴蓬,陈蔚江.合成产物羟乙基淀粉主要质控指标研究[J].药物分析杂志,2004,24(3):296-298. 被引量:6
  • 2李鹤英,张虹,曹维莉,郭齐,吴春玲.羟乙基淀粉导致急性肾功能衰竭13例分析[J].临床荟萃,2004,19(16):953-953. 被引量:2
  • 3姚桂莲,刘健,王淑翠.羟乙基淀粉致过敏性休克死亡[J].药物不良反应杂志,2006,8(3):213-214. 被引量:7
  • 4杨剑辉,梁俊林,王艳侠.羟乙基淀粉诱发老年急性肾功能衰竭18例[J].中国危重病急救医学,1997,9(5):307-308. 被引量:5
  • 5卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 6Hankeln K, Beez M. Haemodynamic and oxygen transport collelates of various volume substitutes in critically ill in-patients with various aetiologies of haemodynamic instability. Inter J Intensive Care 1998; 5: 8.
  • 7McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia[J]. Anesth Analg,2003, 96(6): 1572-1577.
  • 8Fakhry SM. Hematologic principles in surgery. In:Sabiston:Textbook[M]. 16th Ed. Philadelphia: W.B.Saunders Company. 2001.68.
  • 9Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials[J]. BMJ, 1998, 317(7153): 235-240.
  • 10Allison SP, Lobo DN. Debate: Albumin administration should not be avoided[J]. Crit Care, 2000, 4(3): 147-150.

共引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部